FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897746696> ?p ?o ?g. }

• W2897746696 abstract "The number of people with diabetes is growing rapidly. Diabetes can cause nerve damage leading to severe pain in the feet, legs and hands, which is known as diabetic peripheral neuropathic pain (DPNP). In the UK, the National Institute for Health and Care Excellence (NICE) recommends amitriptyline, duloxetine, pregabalin or gabapentin as initial treatment for DPNP. If this is not effective, adding one of the other drugs in combination with the first is recommended. NICE points out that these recommendations are not based on robust evidence. The OPTION-DM randomised controlled trial has been designed to address this evidence deficit, with the aims of determining the most clinically beneficial, cost-effective and tolerated treatment pathway for patients with DPNP. A multicentre, double-blind, centre-stratified, multi-period crossover study with equal allocation to sequences (1:1:1:1:1:1) of treatment pathways. Three hundred and ninety-two participants will be recruited from secondary care DPNP centres in the UK. There are three treatment pathways: amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline and duloxetine supplemented with pregabalin. All participants will receive all three pathways and randomisation will determine the order in which they are received. The primary outcome is the difference between 7-day average 24-h pain scores on an 11-point NRS scale measured during the final follow-up week of the treatment pathway. Secondary outcomes for efficacy, cost-effectiveness, safety, patient-perceived tolerability and subgroup analysis will be measured at week 6 and week 16 of each pathway. The study includes direct comparisons of the mainstay treatment for DPNP. This novel study is designed to examine treatment pathways and capture clinically relevant outcomes which will make the results generalisable to current clinical practice. The study will also provide information on health economic outcomes and will include a subgroup study to provide information on whether patient phenotypes predict response to treatment. ISRCTN17545443 . Registered on 12 September 2016." @default.
• W2897746696 created "2018-10-26" @default.
• W2897746696 creator A5004398518 @default.
• W2897746696 creator A5011919997 @default.
• W2897746696 creator A5012315210 @default.
• W2897746696 creator A5016068781 @default.
• W2897746696 creator A5018623757 @default.
• W2897746696 creator A5026853198 @default.
• W2897746696 creator A5028420877 @default.
• W2897746696 creator A5070819440 @default.
• W2897746696 creator A5080948980 @default.
• W2897746696 creator A5086734076 @default.
• W2897746696 creator A5087325090 @default.
• W2897746696 creator A5087351248 @default.
• W2897746696 date "2018-10-22" @default.
• W2897746696 modified "2023-09-25" @default.
• W2897746696 title "Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial" @default.
• W2897746696 cites W1838295988 @default.
• W2897746696 cites W1873305365 @default.
• W2897746696 cites W1943094646 @default.
• W2897746696 cites W1967052683 @default.
• W2897746696 cites W1970747203 @default.
• W2897746696 cites W1971440802 @default.
• W2897746696 cites W1988979613 @default.
• W2897746696 cites W1997539987 @default.
• W2897746696 cites W1998350079 @default.
• W2897746696 cites W2004791658 @default.
• W2897746696 cites W2005540257 @default.
• W2897746696 cites W2014670473 @default.
• W2897746696 cites W2024753057 @default.
• W2897746696 cites W2039898366 @default.
• W2897746696 cites W2041635174 @default.
• W2897746696 cites W2055763064 @default.
• W2897746696 cites W2055846831 @default.
• W2897746696 cites W2076964900 @default.
• W2897746696 cites W2082850379 @default.
• W2897746696 cites W2084567915 @default.
• W2897746696 cites W2095437242 @default.
• W2897746696 cites W2115451671 @default.
• W2897746696 cites W2120306614 @default.
• W2897746696 cites W2122259487 @default.
• W2897746696 cites W2125316317 @default.
• W2897746696 cites W2149594634 @default.
• W2897746696 cites W2152953447 @default.
• W2897746696 cites W2153789216 @default.
• W2897746696 cites W2154093711 @default.
• W2897746696 cites W2155412494 @default.
• W2897746696 cites W2159609548 @default.
• W2897746696 cites W2160816722 @default.
• W2897746696 cites W2161344815 @default.
• W2897746696 cites W2162902338 @default.
• W2897746696 cites W2166281097 @default.
• W2897746696 cites W2343426002 @default.
• W2897746696 cites W2587561019 @default.
• W2897746696 cites W4247903468 @default.
• W2897746696 doi "https://doi.org/10.1186/s13063-018-2959-y" @default.
• W2897746696 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6196556" @default.
• W2897746696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30348206" @default.
• W2897746696 hasPublicationYear "2018" @default.
• W2897746696 type Work @default.
• W2897746696 sameAs 2897746696 @default.
• W2897746696 citedByCount "11" @default.
• W2897746696 countsByYear W28977466962019 @default.
• W2897746696 countsByYear W28977466962020 @default.
• W2897746696 countsByYear W28977466962021 @default.
• W2897746696 countsByYear W28977466962022 @default.
• W2897746696 countsByYear W28977466962023 @default.
• W2897746696 crossrefType "journal-article" @default.
• W2897746696 hasAuthorship W2897746696A5004398518 @default.
• W2897746696 hasAuthorship W2897746696A5011919997 @default.
• W2897746696 hasAuthorship W2897746696A5012315210 @default.
• W2897746696 hasAuthorship W2897746696A5016068781 @default.
• W2897746696 hasAuthorship W2897746696A5018623757 @default.
• W2897746696 hasAuthorship W2897746696A5026853198 @default.
• W2897746696 hasAuthorship W2897746696A5028420877 @default.
• W2897746696 hasAuthorship W2897746696A5070819440 @default.
• W2897746696 hasAuthorship W2897746696A5080948980 @default.
• W2897746696 hasAuthorship W2897746696A5086734076 @default.
• W2897746696 hasAuthorship W2897746696A5087325090 @default.
• W2897746696 hasAuthorship W2897746696A5087351248 @default.
• W2897746696 hasBestOaLocation W28977466961 @default.
• W2897746696 hasConcept C126322002 @default.
• W2897746696 hasConcept C134018914 @default.
• W2897746696 hasConcept C142724271 @default.
• W2897746696 hasConcept C1862650 @default.
• W2897746696 hasConcept C197934379 @default.
• W2897746696 hasConcept C204787440 @default.
• W2897746696 hasConcept C27081682 @default.
• W2897746696 hasConcept C2776468701 @default.
• W2897746696 hasConcept C2776608144 @default.
• W2897746696 hasConcept C2777107010 @default.
• W2897746696 hasConcept C2778375690 @default.
• W2897746696 hasConcept C2780216858 @default.
• W2897746696 hasConcept C2780764818 @default.
• W2897746696 hasConcept C42219234 @default.
• W2897746696 hasConcept C535046627 @default.
• W2897746696 hasConcept C555293320 @default.
• W2897746696 hasConcept C71924100 @default.
• W2897746696 hasConcept C87813604 @default.
• W2897746696 hasConceptScore W2897746696C126322002 @default.

• next